Ariceum Therapeutics
Ariceum Therapeutics (Ariceum) is a private biotech company developing a novel, first in class radiopharmaceutical product for the diagnosis and targeted radiotherapy of certain hard-to-treat cancers.
Total raised
€25M
€25,000,000
Funding rounds
1
Investors
3
distinct backers
Active since
2022-06
latest 2022-06
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood32
base rate 44% for Series A
- ▼ Overdue vs cohort gap
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-06-10 | Series A | €25M | EQT Life Sciences,HealthCap,Ipsen Pharma | View deal → |
Investors
3Related news
Similar companies
same sector or country- Delivery Hero€7.3BGermany · E-commerce
- Enpal€4.6BGermany · Cleantech
- Auxmoney€3.5BGermany · Fintech
- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Celonis€2.1BGermany · Software